Bioactivity of miltefosine against aquatic stages of Schistosoma mansoni, Schistosoma haematobium and their snail hosts, supported by scanning electron microscopy

Parasites and Vectors

Volumn 4, Issue 1, 2011, Pages

  Eissa, Maha M ^a   El Bardicy, Samia ^b   Tadros, Menerva ^b  

^a ALEXANDRIA UNIVERSITY   (Egypt)

^b THEODOR BILHARZ RESEARCH INSTITUTE   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

MILTEFOSINE; ANTHELMINTIC AGENT; DISINFECTANT AGENT; DRUG DERIVATIVE; PHOSPHORYLCHOLINE;

ANTHELMINTIC ACTIVITY; ARTICLE; BIOMPHALARIA ALEXANDRINA; BULINUS TRUNCUTES; CERCARIA; FEMALE; IN VITRO STUDY; MALE; NONHUMAN; SCANNING ELECTRON MICROSCOPY; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMA MANSONI; SNAIL; ANIMAL; BIOMPHALARIA; DRUG EFFECT; PARASITOLOGY; SURVIVAL; ULTRASTRUCTURE;

BIOMPHALARIA ALEXANDRINA; BULINUS; GASTROPODA; SCHISTOSOMA; SCHISTOSOMA HAEMATOBIUM; SCHISTOSOMA MANSONI;

ANIMALS; ANTHELMINTICS; BIOMPHALARIA; DISINFECTANTS; MICROSCOPY, ELECTRON, SCANNING; PHOSPHORYLCHOLINE; SCHISTOSOMA HAEMATOBIUM; SCHISTOSOMA MANSONI; SURVIVAL ANALYSIS;

EID: 79955780872     PISSN: None     EISSN: 17563305     Source Type: Journal    
DOI: 10.1186/1756-3305-4-73     Document Type: Article

References (54)

1. Analogs of alkyllysophospholipids: chemistry. Effects on the molecular level and their consequences for normal and malignant cells. H Brachwitz C Vollgraf, Pharmacol Ther 1995 66 39 82 10.1016/0163-7258(95)00001-W 7630930
2. Development of miltefosine for the leishmaniases. JD Berman, Mini Rev Med Chem 2006 6 145 151 10.2174/138955706775475993 16472183
3. Miltefosine-discovery of the antileishmanial activity of phospholipid derivatives. SL Croft J Engel, Trans R Soc Trop Med Hyg 2006 100 4 S8 16904717
4. Mechanisms of experimental resistance of Leishmania to miltefosine: implications for clinical use. FJ Perez-Victoria MP Sanchez-Canete K Seifert SL Croft S Sundarr S Castanys F Gamarro, Drug Resist Updates 2006 9 26 39 10.1016/j.drup.2006.04.001 (Pubitemid 43928805)
5. Development of miltefosine as an oral treatment for leishmaniasis. H Sindermann J Engel, Trans R Soc Trop Med Hyg 2006 100 Suppl 1 17 S20 16730362
6. Treatment of New World cutaneous leishmaniasis with miltefosine. J Soto J Berman, Trans R Soc Trop Med Hyg 2006 100 34 S40 16930649
7. The activites of four anticancer alkyllysophospholipids against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei. SL Croft D Snowdon V Yardley, J Antimicrob Chemother 1996 38 1041 1047 10.1093/jac/38.6. 1041 9023651 (Pubitemid 27073283)
8. Proinflamatory and cytotoxic effects of hexadecylphosphocholine (miltefosine) against drug-resistant strains of Trypanosoma cruzi. VB Saraiva D Gibaldi JD Previato L Mendonça-previato MT Bozza CG Freire-de-Lima N Heise, Antimicrob Agents Chemother 2002 46 3472 3477 10.1128/AAC.46.11.3472- 3477.2002 12384352 (Pubitemid 35192913)
9. In vitro activity of hexadecylphosphocholine (miltefosine) against metronidazole-resistant and- susceptible strains of Trichomonas vaginalis. C Blaha M Duchne H Aspöck J Walochnik, J Antimicrob Chemother 2006 57 273 278 10.1093/jac/dki417 16344287 (Pubitemid 43160169)
10. Effects of miltefosine and other alkylphosphocholines on human intestinal parasite Entamoeba histolytica. K Seifert M Duchenne WH Wernsdorfer H Kollaritsch O Scheiner G Wiedermann T Hottokowitz H Eibl, Antimicrob Agents Chemother 2001 45 1505 1510 10.1128/AAC.45.5.1505-1510.2001 11302818 (Pubitemid 32374125)
11. Cytotoxic activites of alkylphosphocholines against clinical isolates of Acanthamoeba spp. J Walochnik M Duchene K Seifert A Obwaller T Hottkowitz G Wiedermann H Eibl H Aspock, Antimicrob Agents Chemother 2002 44 695 701 (Pubitemid 34157653)
12. In- vitro activity of miltefosine and voriconazole on clinical isolates of free-living amehas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri. FL Schuster BJ Guglielmo GS Visvesvara, J Eukaryot Microbial 2006 53 121 126 10.1111/j.1550-7408.2005.00082.x (Pubitemid 43357017)
13. Anti-Acanthamoeba efficacy & toxicity of miltefosine in an organotypic skin equivalent. J Walochnik A Obwaller F Gruber M Mildner E Tschachler M Suchomel M Duchene H Auer, J Antimicrob Chemother 2009 64 539 545 10.1093/jac/dkp215 19549672
14. Hexadecylphosphocholine (miltefosine) has broad-spectrum fungicidal activity and is efficacious in a mouse model of cryptococcosis. F Widmer LC Wright D Obando R Handke R Ganendren DH Ellis TC Sorrell, Antimicrob Agents Chemother 2006 50 2 414 412 10.1128/AAC.50.2.414-421.2006 16436691
15. In vitro bactericidal activity of the antiprotozoal drug miltefosine against Streptococcus pneumoniae and other pathogenic Streptococci. D Llull L Rivas E Garcia, Antimicrob Agents Chemother 2007 51 1844 1848 10.1128/AAC.01428-06 17353242 (Pubitemid 46744170)
16. AKT inhibitors as an HIV-1 infected macrophage-specific anti-viral therapy. P Chugh B Bradel-Tretheway CM Monteiro-Filho P Vicente M Sanjay D Stephen k Baek, Retrovirology 2008 5 11 10.1186/1742-4690-5-11 18237430
17. Miltefosine, a promising novel agent for Schistosomiasis mansoni. MM Eissa MZ EL-Azzouni EI Amer NM Baddour, Int J Parasitol 2011 41 235 242 10.1016/j.ijpara.2010.09.010 21055404
18. Prevenion and control of schistosomiasis and soil transmitted helminthiasis. World Health Organization (WHO), Report of a WHO Expert Committee, Geneva. WHO Technical Report Series 2002 912 1 57
19. Schistosomiasis: challange for control, treatment and drug resistance. A Fenwick JP Webster, Curr Opin Infect Dis 2006 19 577 582 10.1097/01.qco. 0000247591.13671.6a 17075334 (Pubitemid 44665464)
20. Praziquantel, a new board-spectrum antischistosomal agent. R Gonnert P Andrew, Z Parasitenkd 1977 52 129 150 10.1007/BF00389899 410178
21. Praziquantel for the treatment of schistosomiasis: its use for control in areas with endemic disease and prospects for drug resistance. MJ Doenhoff L Pica-Mattoccia, Expert Rev Anti infe 2006 4 199 210 10.1586/14787210.4.2.199
22. Towards control of schistosomiasis in sub-Saharan Africa. VR Southgate D Rollinson A Tchuen Tchuente P Hagan, J Helminthol 2005 79 181 185 10.1079/JOH2005307 16153310 (Pubitemid 41192530)
23. Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers. M Ismail S Botros A Metwally S William A Farghally LF Tao TA Day JL Bennett, Am J Trop Med Hyg 1999 60 932 935 10403323 (Pubitemid 29296217)
24. Resistance of Schistosoma mansoni to praziquantel: Is there a problem ? M Doenhoff JR Kusel GC Coles D Cioli, Trans R Soc Trop Med Parasitol 2002 96 465 469 10.1016/S0035-9203(02)90405-0 (Pubitemid 35386215)
25. Case report: Schistosoma mansoni infection: failure of standard treatment with praziquantel in a returned traveler. SD Lawn SB Lucas PL Chiodini, Trans R Soc Trop Med Hyg 2003 97 100 101 10.1016/S0035-9203(03)90038-1 12886814 (Pubitemid 36874057)
26. Failure of standard treatment with praziquantel in two returned travelers with Schistosoma haematobium infection. D Alonso J Munoz J Gascn ME Valls M Corachan, Am J Trop Med Hyg 2006 74 342 344 16474094 (Pubitemid 46774351)
27. Praziquantel resistance. SS Botros J Bennett, Expert Opin Drug Discov 2007 2 35 S40 10.1517/17460441.2.S1.S35 (Pubitemid 47611476)
28. World Health Organization (WHO), Epidemiology and control of schistosomiasis WHO Technical Report Series 1980 643
29. Molluscicide screening and Evaluation. World Health Organization (WHO), Bull World Health Organ 1965 33 567 581 5295001
30. Large-scale in vitro screening of Egyptian native and cultivate plants for schistosomicidal activity. F Yousif MS Hifnawy G Soliman L Boulos TH Labib S Mahmoud F Ramzy M Yousif I Hassan K Mahmoud SM El-Hallouty M EL-Gendy L Gohar M EL-Manawaty BS EL-Menshawi, Pharma Biol 2007 45 501 510 10.1080/ 13880200701389425 (Pubitemid 47123966)
31. Schistosoma Challenge in compound screening. B Ramirez Q Bickle F Yousif MA Mouries S Nwaka, Expert opinion Drug Discovery 2007 2 1 9 10.1517/17460441.2.1.1 (Pubitemid 47073093)
32. Schistosoma mansoni : structural damage and tegumental repair after in vivo treatment with praziquantel. MK Shaw DA Erasmus, Parasitology 1987 94 243 254 10.1017/S0031182000053920 3108831 (Pubitemid 17043463)
33. Therapeutic and operational profiles of metrifonate and praziquantel in Schistosoma haematobium infection. H Feldmeier L Chitsulo, Arzneimittelforschung 1999 49 557 565 10442201 (Pubitemid 29334747)
34. Treatment of urinary schistosomiasis: methodological issues and research needs identified through a cochrane systematic review. A Danso-Appiah P Gamer PL Olliaro J Utzinger, Parasitology 2009 136 1837 1849 10.1017/S0031182009005939 19493363
35. Mapping and sequencing of acetylcholinestrase genes from the platyhelmimth blood fluke Schistosoma. GN Bentley AK Jones A Agnew, Gene 2003 18 103 112 (Pubitemid 37186923)
36. Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials. J Utzinger J Keiser X Shuhua M Tanner BH Singer, Antimicrob Agents Chemother 2003 47 1487 1495 10.1128/AAC.47.5.1487-1495.2003 12709312 (Pubitemid 36548527)
37. Scanning electron microscopy of integumental surface of Schistosoma manosni. FH Miller GS Tulloch RE Kuntz, J Parasitol 1972 58 6 93 698
38. Ultrastructure of the tegument of Schistosoma. DJ Hockley, Adv Parasi 1973 11 232 305
39. Morphological effects and tegumental alterations induced by mefloquine on schistosomula and adult flukes of Schistosoma mansoni. T Manneck YO Haggenmuller J Keiser, Parasitolog 2010 137 85 98 10.1017/S0031182009990965
40. Role of granulocyte oxygen products in damage of Schistosoma mansoni eggs in vitro. JW Kazura P De Brito J Rabbege M Alkawa, J Clin Invest 1985 75 1297 1307 10.1172/JCI111830 2985656 (Pubitemid 15087160)
41. Schistosoma mansoni phenol oxidase's role in egg shell formation. JL Seed JL Bennett, Exp Parasitol 1980 49 430 441 10.1016/0014-4894(80)90077-6 6245906 (Pubitemid 10030984)
42. The immunopathogenesis of schistosomiasis: a multi-disciplinary approch. KS Warren, Trans R Soc Trop Med Hyg 1972 66 417 437 10.1016/0035-9203(72)90273-8 4558286
43. Scanning electron microscop observations on the miracidium of Schistosoma. PT LoVerde, Int J Parasitol 1975 5 95 97 10.1016/0020-7519(75) 90104-6 1112635
44. Comparative scanning electron microscope (SEM) study of miracidia of four human Schistosoma species. DT Eklu-Natey J Wuest Z Swiderski HP Striebel H Huggel, Int J Parasitol 1985 15 33 42 10.1016/0020-7519(85)90098-0 3980140 (Pubitemid 15081120)
45. The cercarial glycocalyx of Schistosoma mansoni. JC Samuelson JP Caulfield, J Cell Biol 1985 100 1423 1434 10.1083/jcb.100.5.1423 2985622 (Pubitemid 15098017)
46. Scanning electron microscopical studies on Schistosoma mansoni cercariae exposed to ultraviolet irradiation. Australian. SM Bin Dajem OMS Mostafa, Journal of Basic and Applied Sciences 2007 1 776 784
47. Cercaricidal effect of hinokitiol on Schistosoma mansoni. M Nargis H Sato T Ozaki T Inaba M Chisty H Kamiya, Hirosaki Med J 1997 49 49 57 (Pubitemid 28042111)
48. Transmission elecrton microscopy of Schistosoma mansoni cercariae treated with hinokitiol (- thujaplicin), a compound for potential skin application against cercarial penetration. MM Chisty M Nargis T Inaba K Ishita A Osanai H Kamiya, Tohoku J Exp Med 2004 202 63 67 10.1620/tjem.202.63 14738326 (Pubitemid 38128820)
49. Effects of Praziquantel and artesunate on the tegument of adult Schistosoma mekongi harboured in mice. W Jiraungkoorskul S Sahaphong P Sobhon S Riengrojpitak N Kangwanrangsan, Parasitol Int 2005 54 177 183 10.1016/j.parint.2005.04.001 15925540 (Pubitemid 40922915)
50. Morphological changes of adherent and nonadherent cells by treatment with hexadecylphosphocholine and 1-O-octadecyl-2-O-methyl-rac-glycero-3- phosphocholine observed by scanning electron microscopy. P Kaufmann-Kolle EA Fleer, Prog Exp Tumor Res 1992 34 47 58 1438802
51. I-New possible molluscicide from Calendula micrantha officinalis and Ammi majus. II-molluscidial physiological and egg lying affect against Biomphalaria alexandrina and Bulinus truncatus snails. SM Rawi HI El-Gindy A Abdel Kader, J Ecotoxicol Environ Safety 1996 35 261 267 10.1006/eesa.1996.0109 (Pubitemid 27057472)
52. Agave angustifolia: A potential source of control agents against Schistosomiasis mansoni. MM Tadros SM Abdel-Khalik F Melek NM Gaber, New Egypt J Med 2008 39 169 176
53. Molluscicidal activity of some Solanum species extracts against the snail Biomphalaria alexandrina. GT El-Sherbini RA Zayed ET El-Serbini, J Parasito Res 2009 10.1155/2009/474360
54. Molluscicidal efficacies of different formulations of niclosamide: result of meta-analysis of Chinese literature. G Yang W Li L Sun F Wu K Yang Y Huang X Zhou, Parasit Vectors 2010 3 84 10.1186/1756-3305-3-84 20819229